RxDoctor Payments Data

Jason Shapiro, MD

Internal Medicine · Miami Beach, FLNPI 1457346165

Payments from drug & device makers

What this record shows

This record is dominated by gifts: $67,866 of the $69,222 with a category attached, or 98.0%. AbbVie accounts for 98.4% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2019 at $68,169 and has fallen 99.8% since, to $140 in 2025. Among internal medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$69,222in general payments, 2019–2025

Across 71 payments — averaging $974.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$68K
  • Galderma Laboratories, L.p.$884
  • Amgen$119
  • Lilly USA, LLC$99

What the payments were for

  • Food & beverage$1,3562%
  • Gifts$67,86698%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie17$68,120
Galderma Laboratories, L.p.52$884
Amgen1$119
Lilly USA, LLC1$99

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$69,222 in reported general payments places this provider in the 95th percentile of 8,530 internal medicine providers in Florida.

See all internal medicine providers in Florida →

Medicare billing

Part B allowed, 2024
$177,679
Medicare patients
19
Services billed
13,198

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Metformin Hcl11$240

Paid to pharmacies, not to this prescriber.

Other internal medicine in Miami Beach

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →